5th International Conference and Exhibition on Pharmaceutical Science and Technology
June 21-23, 2022
Bangkok, Thailand

Invited lecture:
Lipid-based Nanocarriers for Oral Delivery of Therapeutic Peptides: Hype or Hope?
Prof. Dr. A. Bernkop-Schnürch
more...

13th Global Drug Delivery & Formulation Summit
June 27-29, 2022
Berlin, Germany

Invited lecture:
Novel Nanotechnologies for Mucosal Delivery of Small Molecules and Biologics: Old Problems but New Solutions
Prof. Dr. A. Bernkop-Schnürch
more...

Formulation development is always an important step in the drug development process. We support our clients' projects from initial feasibility studies, to highly efficient, optimised drug delivery systems and product development. With our extensive experience, flexible services, and innovative technologies we are well positioned to put you ahead of your competitors. ThioMatrix provides clients with the experience, science, and know-how necessary to take their pharmaceutical products to the market. Drug delivery systems developed by ThioMatrix allow you to:

• improve the bioavailability of your drug
  
  
• improve the therapeutic efficacy
  
  
• reduce side effects
  
  
• improve stability
  
  
• achieve demanded delivery profiles that meet specific therapy requirements

  * zero-order release kinetics
  
  * sustained drug release

  * targeted drug release

• improve patient compliance
  
  
• generate additional intellectual property

Non-invasive drug delivery systems such as oral, nasal, buccal or vaginal drug delivery systems are highly favoured by patients. In comparison to parenteral delivery systems non-invasive delivery systems offer a much greater ease of application guaranteeing consequently a higher compliance and therapeutic efficacy.

Download a brochure

A. Bernkop-Schnürch, CSO ThioMatrix, was honored with the Gattefossé North America Award 2017
more....